{ "items" : [
    { "id" : "http://dbpedia.org/resource/Quark_Pharmaceuticals"
      "properties" : {
        "http://www.w3.org/2000/01/rdf-schema#comment" : [ "Quark Pharmaceuticals is a pharmaceutical company that develops RNA interference-based treatments for chronic and acute diseases.The company uses state of the art RNA interference technology to develop siRNAs, which inhibit targeted genes from producing proteins associated with certain diseases.The REDD14NP, one of Quark's lead candidate products for the treatment of AMD or age-related macular degeneration, is reported by the U.S." ] ,
        "http://xmlns.com/foaf/0.1/name" : [ "Quark Pharmaceuticals, Inc." ] ,
        "http://xmlns.com/foaf/0.1/homepage" : [ "http://www.quarkpharma.com/" ] ,
        "http://dbpedia.org/ontology/foundingYear" : [ "1993Z" ] ,
        "http://dbpedia.org/ontology/industry" : [ "http://dbpedia.org/resource/Health_care" ] ,
        "http://dbpedia.org/ontology/location" : [ "http://dbpedia.org/resource/California",
          "http://dbpedia.org/resource/United_States",
          "http://dbpedia.org/resource/Israel",
          "http://dbpedia.org/resource/Ness_Ziona",
          "http://dbpedia.org/resource/Fremont,_California" ] ,
        "http://dbpedia.org/ontology/numberOfEmployees" : [ 70 ] ,
        "http://dbpedia.org/ontology/type" : [ "http://dbpedia.org/resource/Privately_held_company"] } } }
